Molecular mechanisms of aberrant fatty acids metabolism in driving cardiovascular diseases: key regulatory targets and dietary interventions

, FFARs, AMPK activators) in the prevention and treatment of CVDs. It also emphasizes the need for further clinical studies to verify the efficacy and mechanisms of these approaches. Overall, this review provides a comprehensive theoretical framework for understanding the role of FAs metabolism in CVDs and outlines directions for developing novel therapeutic strategies.